Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Syntrillo Telehealth Stroke Risk Reduction Study

NCT: NCT07124728 · TERMINATED

NCT IDNCT07124728
StatusTERMINATED
Start Date2025-07-30
Completion2026-07-22
SponsorSyntrillo, Inc (OTHER)
First posted
Last updated

Brief Summary

A prospective, single-arm, open-label study evaluating the impact of Syntrillo's telehealth program on stroke risk factors, particularly blood pressure, among 68 high-risk patients. The 6-month intervention includes personalized remote care with blood pressure monitoring, wearable tracking, and multidisciplinary telehealth visits.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑